Connect with us

Clozaril (clozapine)

Clozapine (or CLOZARIL®) is mainly prescribed to treat treatment-resistant schizophrenia.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2015

Dosage Forms: 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg, 500 mg, 600 mg, 700 mg, 800 mg, 900 mg

Biological Half-life: 6-26 hours

Side Effects: Constipation, bed-wetting, muscle stiffness, tremors, dizziness, orthostatic hypotension, hyperglycemia, weight gain

Serious Risks: Low white blood cells (agranulocytosis), myocarditis, gastrointestinal hypomotility

Routes of Administration: Oral

Pregnancy Category: B (US)


Twitter Feed

Writing a to-do list during bedtime may help you fall asleep faster, study suggests #insomnia #sleep

Caffeine found to be a reliable biomarker of early-stage Parkinson’s disease #neurology #Parkinsons

Video game addiction to be recognized as a mental condition #gamingdisorder #videogaming